GlassScriptPhysician profile
Leia M Medlock
NPI 1659531077
$6,604.25
in general payments reported to CMS, 2019-2025
19 companies · $5,551 in 2025
The $5,551 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177 · 2021: $225 · 2024: $651 · 2025: $5,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,613 · Food and Beverage: $1,370 · Travel and Lodging: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,613.12 |
| Food and Beverage | $1,369.53 |
| Travel and Lodging | $219.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,759.88 | 2025 | |
| Hologic Sales and Service, LLC | $353.30 | 2024-2025 | Novasure, Acessa Provu System, Coolseal Generator |
| Baxter Healthcare | $291.41 | 2024 | Floseal, Tisseel, Perclot |
| Cerner Corporation | $225.00 | 2021 | |
| Astellas Pharma US INC | $180.28 | 2025 | Veozah |
| Avanos Medical | $142.88 | 2024-2025 | On-Q Pump and Accessories, On-Q* Pump and Accessories |
| Sumitomo Pharma America, INC. | $93.11 | 2024-2025 | Myfembree, Gemtesa |
| Organon LLC | $91.97 | 2024-2025 | Nexplanon |
| Smith+Nephew, INC. | $78.30 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $77.54 | 2024-2025 | Vpriv |
| Mayne Pharma Commercial LLC | $67.17 | 2025 | |
| Aspira Women'S Health INC | $66.44 | 2019 | |
| Mimedx Group, INC. | $63.23 | 2025 | |
| Optumhealth Care Solutions, LLC | $26.94 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Conmed Corporation | $20.04 | 2025 | Airseal |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $18.07 | 2025 | Zurzuvae |
| Allergan, INC. | $17.41 | 2019 | |
| Amgen INC. | $16.65 | 2025 | Evenity |
| Merck Sharp & Dohme LLC | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leia Medlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.